GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (OTCPK:SBMFF) » Definitions » Days Payable

Sino Biopharmaceutical (Sino Biopharmaceutical) Days Payable : 107.01 (As of Jun. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Sino Biopharmaceutical Days Payable?

Sino Biopharmaceutical's average Accounts Payable for the six months ended in Jun. 2023 was $267 Mil. Sino Biopharmaceutical's Cost of Goods Sold for the six months ended in Jun. 2023 was $455 Mil. Hence, Sino Biopharmaceutical's Days Payable for the six months ended in Jun. 2023 was 107.01.

The historical rank and industry rank for Sino Biopharmaceutical's Days Payable or its related term are showing as below:

SBMFF' s Days Payable Range Over the Past 10 Years
Min: 63.17   Med: 105.53   Max: 136.32
Current: 125.41

During the past 13 years, Sino Biopharmaceutical's highest Days Payable was 136.32. The lowest was 63.17. And the median was 105.53.

SBMFF's Days Payable is ranked worse than
53.22% of 714 companies
in the Biotechnology industry
Industry Median: 146.16 vs SBMFF: 125.41

Sino Biopharmaceutical's Days Payable declined from Jun. 2022 (137.39) to Jun. 2023 (107.01). It may suggest that Sino Biopharmaceutical accelerated paying its suppliers.


Sino Biopharmaceutical Days Payable Historical Data

The historical data trend for Sino Biopharmaceutical's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Days Payable Chart

Sino Biopharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 136.19 128.00 122.88 109.92 110.15

Sino Biopharmaceutical Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 116.76 137.39 142.36 107.01 182.44

Competitive Comparison of Sino Biopharmaceutical's Days Payable

For the Biotechnology subindustry, Sino Biopharmaceutical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sino Biopharmaceutical's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's Days Payable distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's Days Payable falls into.



Sino Biopharmaceutical Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Sino Biopharmaceutical's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

Days Payable (A: Dec. 2022 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2021 ) + Accounts Payable (A: Dec. 2022 )) / count ) / Cost of Goods Sold (A: Dec. 2022 )*Days in Period
=( (265.83 + 234.857) / 2 ) / 831.291*365
=250.3435 / 831.291*365
=109.92

Sino Biopharmaceutical's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

Days Payable (Q: Jun. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2022 ) + Accounts Payable (Q: Jun. 2023 )) / count ) / Cost of Goods Sold (Q: Jun. 2023 )*Days in Period
=( (234.857 + 298.435) / 2 ) / 454.73*365 / 2
=266.646 / 454.73*365 / 2
=107.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sino Biopharmaceutical Days Payable Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Sino Biopharmaceutical (Sino Biopharmaceutical) Business Description

Traded in Other Exchanges
Address
1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG
Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.

Sino Biopharmaceutical (Sino Biopharmaceutical) Headlines

From GuruFocus

Matthews China Fund Comments on Sino Biopharmaceutical

By Sydnee Gatewood Sydnee Gatewood 01-28-2020

Matthews China Fund 3rd Quarter Commentary

By Holly LaFon Holly LaFon 10-19-2017

Value Idea Contest: Sino Biopharmaceutical

By Matthew Sipos Matthew Sipos 01-10-2019

Matthews China Fund Comments on Sino Biopharmaceutical

By Vera Yuan Vera Yuan 10-20-2014

GuruFocus Value Idea Contest Sees 2 Winners!

By Holly LaFon Holly LaFon 07-12-2019

Matthews China Fund Comments on Sino Biopharmaceutical

By Sydnee Gatewood Sydnee Gatewood 10-25-2019